Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 2
1948 12
1949 1
1951 13
1952 30
1953 41
1954 44
1955 40
1956 46
1957 34
1958 41
1959 35
1960 37
1961 33
1962 24
1963 1
1964 6
1965 50
1966 82
1967 110
1968 100
1969 100
1970 104
1971 133
1972 118
1973 138
1974 122
1975 118
1976 145
1977 133
1978 153
1979 190
1980 178
1981 179
1982 151
1983 181
1984 203
1985 194
1986 177
1987 175
1988 210
1989 206
1990 182
1991 177
1992 193
1993 239
1994 234
1995 268
1996 275
1997 242
1998 263
1999 296
2000 361
2001 427
2002 413
2003 439
2004 483
2005 547
2006 566
2007 550
2008 619
2009 616
2010 697
2011 709
2012 773
2013 859
2014 915
2015 950
2016 871
2017 926
2018 912
2019 924
2020 804
2021 632
2022 247
2023 199
2024 148

Text availability

Article attribute

Article type

Publication date

Search Results

20,127 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis.
Lebwohl MG, Stein Gold L, Strober B, Papp KA, Armstrong AW, Bagel J, Kircik L, Ehst B, Hong HC, Soung J, Fromowitz J, Guenthner S, Piscitelli SC, Rubenstein DS, Brown PM, Tallman AM, Bissonnette R. Lebwohl MG, et al. N Engl J Med. 2021 Dec 9;385(24):2219-2229. doi: 10.1056/NEJMoa2103629. N Engl J Med. 2021. PMID: 34879448 Clinical Trial.
Palovarotene: First Approval.
Hoy SM. Hoy SM. Drugs. 2022 Apr;82(6):711-716. doi: 10.1007/s40265-022-01709-z. Drugs. 2022. PMID: 35384641 Review.
Endometrial thickness in tamoxifen-treated women.
Li YT, Chang WH, Wang PH. Li YT, et al. Taiwan J Obstet Gynecol. 2023 Nov;62(6):799-801. doi: 10.1016/j.tjog.2023.09.016. Taiwan J Obstet Gynecol. 2023. PMID: 38008496 Free article. No abstract available.
Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial.
Baek SY, Noh WC, Ahn SH, Kim HA, Ryu JM, Kim SI, Lee EG, Im SA, Jung Y, Park MH, Park KH, Kang SH, Jeong J, Park E, Kim SY, Lee MH, Kim LS, Lim W, Kim S, Kim HJ. Baek SY, et al. J Clin Oncol. 2023 Nov 1;41(31):4864-4871. doi: 10.1200/JCO.23.00557. Epub 2023 Aug 22. J Clin Oncol. 2023. PMID: 37607321 Clinical Trial.
Resveratrol-Induced Signal Transduction in Wound Healing.
Pignet AL, Schellnegger M, Hecker A, Kohlhauser M, Kotzbeck P, Kamolz LP. Pignet AL, et al. Int J Mol Sci. 2021 Nov 23;22(23):12614. doi: 10.3390/ijms222312614. Int J Mol Sci. 2021. PMID: 34884419 Free PMC article. Review.
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα+ breast cancer.
Poulard C, Ha Pham T, Drouet Y, Jacquemetton J, Surmielova A, Kassem L, Mery B, Lasset C, Reboulet J, Treilleux I, Marangoni E, Trédan O, Le Romancer M. Poulard C, et al. EMBO Mol Med. 2023 Aug 7;15(8):e17248. doi: 10.15252/emmm.202217248. Epub 2023 Jul 17. EMBO Mol Med. 2023. PMID: 37458145 Free PMC article.
20,127 results
You have reached the last available page of results. Please see the User Guide for more information.